EDGAR Filing Documents for 0001104659-17-033537

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001104659-17-033537

Filing Date

2017-05-17

Accepted

2017-05-17 19:01:18

Documents

Period of Report

2017-02-16

Document Format Files

Seq	Description	Document	Type	Size
1	4	a4.html	4
1	4	a4.xml	4	18884
	Complete submission text file	0001104659-17-033537.txt		20228

Mailing Address C/O DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR MORRISTOWN NJ 07960

Business Address

Type: 4 | Act: 34 | File No.: 001-37558 | Film No.: 17853143

Mailing Address LEBERSTRASSE 20 VIENNA C4 1110

Business Address LEBERSTRASSE 20 VIENNA C4 1110 43 (0)1 740 93-0

IRS No.: 000000000 | State of Incorp.: C4 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations